The Zhitong Finance App learned that the latest data from the Hong Kong Stock Exchange shows that on October 28, UBS Group AG increased its holdings of Hengrui Pharmaceutical (01276.HK) by 1,117,000 shares, at a price of HK$49.8626 per share, for a total amount of about HK$556.65 million. After the increase in holdings, the latest number of shares held was approximately 13.4574 million shares, and the latest shareholding ratio was 5.21%.

The Zhitong Finance App learned that the latest data from the Hong Kong Stock Exchange shows that on October 28, UBS Group AG increased its holdings of Hengrui Pharmaceutical (01276.HK) by 1,117,000 shares, at a price of HK$49.8626 per share, for a total amount of about HK$556.65 million. After the increase in holdings, the latest number of shares held was approximately 13.4574 million shares, and the latest shareholding ratio was 5.21%.